A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Start Date
12/6/2024
Completion Date
12/31/2028
Summary
The purpose of this study is to determine whether JNJ-90301900 added to concurrent platinum-based doublet chemotherapy with radiation therapy (cCRT) followed by consolidation immunotherapy (cIT) can improve objective response rate (ORR; that is percentage of participants whose best response is complete response or partial response during the study) in participants with locally advanced and unresectable stage III non-small cell lung cancer.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
JNJ-90301900
Durvalumab
Concurrent Chemo/Radiation Therapy (cCRT)
Concurrent Chemo/Radiation Therapy (cCRT): Carboplatin
Concurrent Chemo/Radiation Therapy (cCRT): Paclitaxel
Conditions
Locations
Moores Cancer Center at UC San Diego Health
La Jolla, California 92037
United States
University of Connecticut Health Center
Farmington, Connecticut 06030
United States
Yale University
New Haven, Connecticut 06519
United States
University of Miami
Miami, Florida 33136
United States
Orlando Health Cancer Institute
Orlando, Florida 32806
United States
Emory University Winship Cancer Institute
Atlanta, Georgia 30306
United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215
United States
Washington University in St Louis
St Louis, Missouri 63130
United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey 08901
United States
NYU Langone Health
New York, New York 10016
United States
Memorial Sloan Kettering Cancer Center
New York, New York 10065
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina 27514
United States
FirstHealth of the Carolinas
Pinehurst, North Carolina 28374
United States
University Hospitals Cleveland Medical Center
Cleveland, Ohio 44106
United States
Oregon Health And Science University
Portland, Oregon 97239
United States
University of Pennsylvania
Philadelphia, Pennsylvania 19104
United States
MD Anderson Cancer Center
Houston, Texas 77030
United States
University of Vermont Medical Center
Burlington, Vermont 05401
United States
Royal Brisbane and Women's Hospital
Herston, 4029
Australia
Sir Charles Gairdner Hospital
Nedlands, 6009
Australia
Macquarie University
North Ryde, 2109
Australia
Royal Melbourne Hospital
Parkville, 3050
Australia
Fundacao Pio XII
Barretos, 14784 400
Brazil
Sociedade Beneficente de Senhoras Hospital Sirio Libanes
São Paulo, 01308 050
Brazil
Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
São Paulo, 05651 901
Brazil
Dongguan People s Hospital
Dongguan, 523109
China
The First Affiliated Hospital Sun Yat sen University
Guangzhou, 510080
China
The Affiliated Cancer Hospital of Shandong First Medical University
Jinan, 250117
China
Hopital De La Cavale Blanche
Brest, 29200
France
Hopital Nord Marseille
Marseille, 13015
France
Hopital Tenon
Paris, 75020
France
Institut Curie
Paris, 75248
France
Gustave Roussy
Villejuif, 94805
France
Prince of Wales Hospital
Shatin,
Hong Kong
Antoni van Leeuwenhoek
Amsterdam, 1066 CX
Netherlands
Radboud Umcn
Nijmegen, 6525 GA
Netherlands
Hosp. Univ. 12 de Octubre
Madrid, 28041
Spain
Clinica Univ. de Navarra
Pamplona, 31008
Spain
Hosp. Clinico Univ. de Santiago
Santiago de Compostela, 15706
Spain
Hosp. Univ. I Politecni La Fe
Valencia, 46026
Spain
Marmara University Pendik Training Hospital
Istanbul, 34899
Turkey (Türkiye)
Sakarya University Training and Research Hospital
Sakarya, 54100
Turkey (Türkiye)
University College London Hospitals
London, NW1 2BU
United Kingdom